Medifoxamine
Medifoxamine is a monoamine re-uptake inhibiting antidepressive agent which preferentially inhibits dopamine reuptake[1].
Product Specifications
CAS Number
[32359-34-5]
Product Name Alternative
NPC (hydrochloride),NPC
UNSPSC
12352005
Target
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/medifoxamine.html
Purity
99.34
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
Molecular Formula
C16H19NO2
Molecular Weight
257.33
References & Citations
[1]Saleh S, et al. Ocular hypotensive effects of medifoxamine. Br J Clin Pharmacol. 1992;34 (3) :269-271.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 4
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1482265-01 0.02 mg (E-Coli)
Recombinant Salmonella typhi Probable UDP-N-acetyl-D-mannosaminuronic acid transferase (wecG)
Sign In for Pricing
View Details MBS1482265-02 0.1 mg (E-Coli)
Recombinant Salmonella typhi Probable UDP-N-acetyl-D-mannosaminuronic acid transferase (wecG)
Sign In for Pricing
View Details 
MBS1482265-03 0.02 mg (Yeast)
Recombinant Salmonella typhi Probable UDP-N-acetyl-D-mannosaminuronic acid transferase (wecG)
Sign In for Pricing
View Details MBS1482265-04 0.1 mg (Yeast)
Recombinant Salmonella typhi Probable UDP-N-acetyl-D-mannosaminuronic acid transferase (wecG)
Sign In for Pricing
View Details MBS1482265-05 0.02 mg (Baculovirus)
Recombinant Salmonella typhi Probable UDP-N-acetyl-D-mannosaminuronic acid transferase (wecG)
Sign In for Pricing
View Details